HeartSciences Cash on Hand 2022-2024 | HSCS

HeartSciences cash on hand from 2022 to 2024. Cash on hand can be defined as cash deposits at financial institutions that can immediately be withdrawn at any time, and investments maturing in one year or less that are highly liquid and therefore regarded as cash equivalents and reported with or near cash line items.
HeartSciences Annual Cash on Hand
(Millions of US $)
2023 $2
2022 $1
2021 $1
HeartSciences Quarterly Cash on Hand
(Millions of US $)
2024-01-31 $7
2023-10-31 $0
2023-07-31 $1
2023-04-30 $2
2023-01-31 $2
2022-10-31 $3
2022-07-31 $4
2022-04-30 $1
2022-01-31
2021-10-31
2021-07-31
2021-04-30 $1
Sector Industry Market Cap Revenue
Medical Medical Information Systems $0.005B $0.000B
HeartSciences is an artificial intelligence powered medical technology company focused on transforming ECGs/EKGs to save lives through earlier detection of heart disease. The company's product candidate includes the MyoVista(R) wavECG(TM) or the MyoVista(R). HeartSciences , formerly known as Heart Test Laboratories Inc., is based in Southlake, TX.
Stock Name Country Market Cap PE Ratio
GE HealthCare Technologies (GEHC) United States $37.366B 20.52
Inspire Medical Systems (INSP) United States $4.612B 0.00
Axonics (AXNX) United States $3.446B 0.00
Hims & Hers Health (HIMS) United States $3.129B 0.00
10x Genomics (TXG) United States $2.980B 0.00
Olink Holding AB (publ) (OLK) Sweden $2.978B 0.00
IRhythm Technologies (IRTC) United States $2.950B 0.00
Enovis (ENOV) United States $2.875B 21.30
Azenta (AZTA) United States $2.743B 154.15
Privia Health (PRVA) United States $2.016B 112.67
Schrodinger (SDGR) United States $1.654B 0.00
Omnicell (OMCL) United States $1.398B 48.32
Phreesia (PHR) United States $1.393B 0.00
Standard BioTools (LAB) United States $0.746B 0.00
Fulgent Genetics (FLGT) United States $0.662B 0.00
Definitive Healthcare (DH) United States $0.649B 0.00
Talkspace (TALK) United States $0.467B 0.00
Clover Health Investments (CLOV) United States $0.442B 0.00
Health Catalyst (HCAT) United States $0.410B 0.00
Pulmonx (LUNG) United States $0.349B 0.00
SOPHiA GENETICS SA (SOPH) Switzerland $0.296B 0.00
Butterfly Network (BFLY) United States $0.217B 0.00
P3 Health Partners (PIII) United States $0.191B 0.00
Outset Medical (OM) United States $0.187B 0.00
American Well (AMWL) United States $0.145B 0.00
TruBridge (TBRG) United States $0.134B 7.19
111 (YI) China $0.111B 0.00
MSP Recovery (LIFW) United States $0.107B 0.00
SHL Telemedicine (SHLT) Israel $0.075B 0.00
Future Health ESG (FHLT) United States $0.070B 0.00
Mobile-health Network Solutions (MNDR) Singapore $0.064B 0.00
Augmedix (AUGX) United States $0.059B 0.00
EUDA Health Holdings (EUDA) Singapore $0.057B 0.00
HeartBeam (BEAT) United States $0.055B 0.00
Zepp Health (ZEPP) China $0.054B 0.00
CareCloud (CCLD) United States $0.045B 0.00
Movano (MOVE) United States $0.042B 0.00
Akili (AKLI) United States $0.034B 0.00
ImmunoPrecise Antibodies (IPA) Canada $0.031B 0.00
Bullfrog AI Holdings (BFRG) United States $0.022B 0.00
Streamline Health Solutions (STRM) United States $0.020B 0.00
Cue Health (HLTH) United States $0.015B 0.00
Strata Skin Sciences (SSKN) United States $0.014B 0.00
Syra Health (SYRA) United States $0.010B 0.00
Biotricity (BTCY) United States $0.010B 0.00
Transgenomic (PRPO) United States $0.009B 0.00
Predictive Oncology (POAI) United States $0.007B 0.00
Healthcare Triangle (HCTI) United States $0.004B 0.00
Zhongchao (ZCMD) China $0.003B 0.00
Tivic Health Systems (TIVC) United States $0.001B 0.00
Centogene (CNTG) Germany $0.000B 0.00
MDxHealth SA (MDXH) Belgium $0.000B 0.00
Nyxoah SA (NYXH) Belgium $0.000B 0.00